Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment...
38 insider purchases on record · latest filing 2020-09-11.
Insiders have also filed 65 sale transactions at NERV.